Fen Lan

696 total citations
36 papers, 394 citations indexed

About

Fen Lan is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Fen Lan has authored 36 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Oncology. Recurrent topics in Fen Lan's work include Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Fen Lan is often cited by papers focused on Lung Cancer Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Fen Lan collaborates with scholars based in China, United States and Germany. Fen Lan's co-authors include Huahao Shen, Shaobin Wang, Wen Li, Yang Xia, Zhihua Chen, Weining Xiong, Guopeng Xu, Xiaoxia Lü, Fei Li and Chen Zhu and has published in prestigious journals such as Journal of Clinical Oncology, Science Advances and Annals of Oncology.

In The Last Decade

Fen Lan

34 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fen Lan China 12 142 99 98 69 65 36 394
Mei Hulver United States 9 129 0.9× 59 0.6× 95 1.0× 42 0.6× 28 0.4× 10 359
Jun‐Kai Kao Taiwan 14 207 1.5× 93 0.9× 166 1.7× 122 1.8× 68 1.0× 32 575
Anna Theiler Austria 10 142 1.0× 86 0.9× 86 0.9× 141 2.0× 67 1.0× 11 424
Xinyan Huang China 9 107 0.8× 139 1.4× 70 0.7× 90 1.3× 42 0.6× 31 429
Francis Green Canada 8 90 0.6× 155 1.6× 237 2.4× 63 0.9× 40 0.6× 9 518
Swati Patel India 14 119 0.8× 27 0.3× 108 1.1× 61 0.9× 60 0.9× 22 531
Gimena dos Santos Uruguay 5 233 1.6× 90 0.9× 113 1.2× 24 0.3× 25 0.4× 9 425
Junye Wang China 14 145 1.0× 152 1.5× 133 1.4× 28 0.4× 123 1.9× 42 535
Lucie Roussel Canada 12 193 1.4× 228 2.3× 288 2.9× 167 2.4× 66 1.0× 17 671
Zhixin Song China 16 138 1.0× 89 0.9× 262 2.7× 47 0.7× 60 0.9× 41 623

Countries citing papers authored by Fen Lan

Since Specialization
Citations

This map shows the geographic impact of Fen Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fen Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fen Lan more than expected).

Fields of papers citing papers by Fen Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fen Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fen Lan. The network helps show where Fen Lan may publish in the future.

Co-authorship network of co-authors of Fen Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Fen Lan. A scholar is included among the top collaborators of Fen Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fen Lan. Fen Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lan, Fen, et al.. (2025). Paclitaxel anti-cancer therapeutics: from discovery to clinical use. Chinese Journal of Natural Medicines. 23(7). 769–789. 1 indexed citations
2.
Zhang, Hengdi, et al.. (2022). Optical coherent tomography angiography observation of macular subinternal limiting membrane hemorrhage in CO poisoning: a case report. International Journal of Ophthalmology. 15(11). 1885–1887.
3.
Liu, Zhenjie, Jinyi Chen, Fen Lan, et al.. (2022). Extracorporeal Membrane Oxygenation—First Strategy for Acute Life-Threatening Pulmonary Embolism. Frontiers in Cardiovascular Medicine. 9. 875021–875021. 6 indexed citations
4.
5.
Li, Fei, Xufei Du, Fen Lan, et al.. (2021). Eosinophilic inflammation promotes CCL6-dependent metastatic tumor growth. Science Advances. 7(22). 42 indexed citations
6.
Jin, Rui, Ling Peng, Jiawei Shou, et al.. (2021). EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes. Frontiers in Oncology. 11. 680804–680804. 33 indexed citations
7.
Lan, Fen, Hong Shen, Qiyuan Wang, et al.. (2021). Multi-Dimensional Display of Wang’s Lymph Node Map Using Virtual Bronchoscopic Navigation System. Frontiers in Molecular Biosciences. 8. 679442–679442. 1 indexed citations
8.
Fang, Yong, Hongming Pan, Jiawei Shou, et al.. (2021). Anlotinib plus docetaxel versus docetaxel as second-line treatment for advanced non-small cell lung cancer (NSCLC): Updated results from a phase I/II study.. Journal of Clinical Oncology. 39(15_suppl). e21055–e21055. 2 indexed citations
9.
10.
Lan, Fen, Chen Zhu, Rui Jin, et al.. (2021). Clinical characteristics of COVID-19 patients with complications: implications for management. Therapeutic Advances in Chronic Disease. 12. 364090500–364090500. 2 indexed citations
11.
Gong, Xiaomei, et al.. (2020). Biopharmaceutics and Pharmacokinetics of Timosaponin A-III by a Sensitive HPLC-MS/MS Method: Low Bioavailability Resulting from Poor Permeability and Solubility. Current Pharmaceutical Biotechnology. 22(5). 672–681. 5 indexed citations
12.
13.
Wen, Hua, et al.. (2016). Eosinophil differentiation in the bone marrow is promoted by protein tyrosine phosphatase SHP2. Cell Death and Disease. 7(4). e2175–e2175. 31 indexed citations
14.
Lan, Fen, Chao Cao, Jinkai Liu, & Wen Li. (2015). Obstructive sleep apnea syndrome susceptible genes in the Chinese population: a meta-analysis of 21 case–control studies. Sleep And Breathing. 19(4). 1441–1448. 6 indexed citations
15.
Tian, Baoping, Hua Wen, Yan Jin, et al.. (2014). Exogenous Interleukin-17A Inhibits Eosinophil Differentiation and Alleviates Allergic Airway Inflammation. American Journal of Respiratory Cell and Molecular Biology. 52(4). 459–470. 20 indexed citations
16.
Cao, Chao, Chen Zhu, Timea Palmai‐Pallag, et al.. (2014). Potential Roles of Eosinophils in Cancer Therapy: Epidemiological Studies, Experimental Models, and Clinical Pathology. Recent Patents on Anti-Cancer Drug Discovery. 9(2). 241–248. 10 indexed citations
17.
Li, Wen, Fen Lan, Fugui Yan, & Huahao Shen. (2012). Angiotensin-converting Enzyme I/D Polymorphism is Associated with COPD Risk in Asian Population: Evidence from a Meta-analysis. COPD Journal of Chronic Obstructive Pulmonary Disease. 10(1). 35–39. 10 indexed citations
18.
Zuo, Peng, Shuo Yang, Guopeng Xu, et al.. (2010). Administration of nonviral gene vector encoding rat β‐defensin‐2 ameliorates chronicPseudomonas aeruginosalung infection in rats. The Journal of Gene Medicine. 12(3). 276–286. 12 indexed citations
19.
Xu, Guopeng, Weining Xiong, Peng Zuo, et al.. (2010). Lactoferrin-derived peptides and Lactoferricin chimera inhibit virulence factor production and biofilm formation in Pseudomonas aeruginosa. Journal of Applied Microbiology. 109(4). 1311–1318. 32 indexed citations
20.
Hu, Weikun, Xiaoxia Lü, Shuo Yang, et al.. (2009). Expression of the Th1-Specific Cell-Surface Protein Tim-3 Increases in a Murine Model of Atopic Asthma. Journal of Asthma. 46(9). 872–877. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei Hulver Breakdown of academic impact, for papers by Jun‐Kai Kao Breakdown of academic impact, for papers by Anna Theiler Breakdown of academic impact, for papers by Xinyan Huang Breakdown of academic impact, for papers by Francis Green Breakdown of academic impact, for papers by Swati Patel Breakdown of academic impact, for papers by Gimena dos Santos Breakdown of academic impact, for papers by Junye Wang Breakdown of academic impact, for papers by Lucie Roussel Breakdown of academic impact, for papers by Zhixin Song
Rankless by CCL
2026